Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
435 91, 435 68, 435 70, 4351723, 4353171, 435320, 935 12, C07H 1512, C12P 2102, C12N 1500, C12N 100
A gene of varicella-zoster virus (VZV) which encodes immunogenic outer surface viral proteins has been identified by DNA sequence analysis. This gene can hybrid select messenger RNA which encodes and expresses a protein which reacts with human convalescent zoster sera and with polyclonal monospecific antisera which neutralize viral infectivity. These proteins are useful for the preparation of a vaccine for VZV.
Ellis et al. (1985) J. Virology, vol. 53, pp. 81-88.
Davidson et al. (1985), J. Gen. Virol., vol. 66, pp. 207-220.
Davidson (1983) EMBO J., vol. 2, pp. 2203-2209.
Davison Andrew J.
Ellis Ronald W.
Keller Paul M.
Lowe Robert S.
Levitt Julian S.
Merck & Co. , Inc.
Perrella Donald J.
Pfeiffer Hesna J.
Vaccine against varicella-zoster virus does not yet have a rating. At this time, there are no reviews or comments for this patent.If you have personal experience with Vaccine against varicella-zoster virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine against varicella-zoster virus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-894574